# Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension

> **NCT04908982** · PHASE4 · UNKNOWN · sponsor: **Eastern Virginia Medical School** · enrollment: 60 (estimated)

## Conditions studied

- Pre-Eclampsia

## Interventions

- **DRUG:** Aspirin 81mg

## Key facts

- **NCT ID:** NCT04908982
- **Lead sponsor:** Eastern Virginia Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-28
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908982, "Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04908982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*